Table 2.

Baseline disease characteristics in patients with and without MACE

Parameter, mean (SD)	No MACE (N = 4,024)	Adjudicated MACE (N = 52)
Duration of RA, years	7.7 (7.9)	10.1 (8.8)
DAS28–4(ESR)	6.3 (1.1)	6.3 (1.3)
Tender joint count	14.1 (7.3)	14.3 (7.5)
Swollen joint count	10.4 (5.6)	10.3 (5.9)
TC, mg/dL	198.3 (42.1)	208.2 (48.9)
HDL-c, mg/dL	59.4 (16.9)	55.3 (16.0)
LDL-c, mg/dL	113.9 (34.2)	123.3 (43.2)
TC/HDL-c ratio	3.5 (1.1)	4.0(1.5)
Triglycerides, mg/dL	125.3 (72.6)	152.1 (86.9)
Apolipoprotein A-l, mg/dL	153.6 (31.2)	149.4 (27.8)
Apolipoprotein B, mg/dL	94.4 (24.7)	105.8 (29.4)
CRP, mg/dL	17.1 (22.7)	15.7 (16.9)
ESR, mm/hr	50.4 (26.9)	47.9 (23.8)

CRP = C-reactive protein; DAS28–4 = Disease Activity Score 28–4; ESR = erythrocyte sedimentation rate; HDL-c = high-density lipoprotein cholesterol; LDL-c = low-density lipoprotein cholesterol; MACE = major adverse cardiovascular event; RA = rheumatoid arthritis; SD = standard deviation; TC = total cholesterol